SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-020260
Filing Date
2022-05-16
Accepted
2022-05-16 08:34:45
Documents
86
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tsha-10q_20220331.htm   iXBRL 10-Q 1426322
2 EX-31.1 tsha-ex311_6.htm EX-31.1 20305
3 EX-31.2 tsha-ex312_8.htm EX-31.2 20756
4 EX-32.1 tsha-ex321_7.htm EX-32.1 10214
5 EX-32.2 tsha-ex322_9.htm EX-32.2 10115
6 GRAPHIC gqxupkufbvrp000019.jpg GRAPHIC 241176
7 GRAPHIC gqxupkufbvrp000023.jpg GRAPHIC 1676347
8 GRAPHIC gqxupkufbvrp000013.jpg GRAPHIC 63494
9 GRAPHIC gqxupkufbvrp000012.jpg GRAPHIC 304188
10 GRAPHIC gqxupkufbvrp000018.jpg GRAPHIC 248137
11 GRAPHIC gqxupkufbvrp000011.jpg GRAPHIC 235593
12 GRAPHIC gqxupkufbvrp000022.jpg GRAPHIC 490435
13 GRAPHIC gqxupkufbvrp000017.jpg GRAPHIC 229312
14 GRAPHIC gqxupkufbvrp000007.jpg GRAPHIC 162963
15 GRAPHIC gqxupkufbvrp000004.jpg GRAPHIC 160405
16 GRAPHIC gqxupkufbvrp000006.jpg GRAPHIC 816132
17 GRAPHIC gqxupkufbvrp000016.jpg GRAPHIC 1045614
18 GRAPHIC gqxupkufbvrp000020.jpg GRAPHIC 80538
19 GRAPHIC gqxupkufbvrp000001.jpg GRAPHIC 45397
20 GRAPHIC gqxupkufbvrp000015.jpg GRAPHIC 104357
21 GRAPHIC gqxupkufbvrp000005.jpg GRAPHIC 249401
22 GRAPHIC gqxupkufbvrp000008.jpg GRAPHIC 1139138
23 GRAPHIC gqxupkufbvrp000014.jpg GRAPHIC 226965
24 GRAPHIC gqxupkufbvrp000002.jpg GRAPHIC 148102
25 GRAPHIC gqxupkufbvrp000010.jpg GRAPHIC 307757
26 GRAPHIC gqxupkufbvrp000003.jpg GRAPHIC 238532
27 GRAPHIC gqxupkufbvrp000021.jpg GRAPHIC 288527
28 GRAPHIC gqxupkufbvrp000009.jpg GRAPHIC 236869
  Complete submission text file 0001564590-22-020260.txt   28666099

Data Files

Seq Description Document Type Size
29 XBRL TAXONOMY EXTENSION SCHEMA tsha-20220331.xsd EX-101.SCH 53687
30 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tsha-20220331_cal.xml EX-101.CAL 39280
31 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tsha-20220331_def.xml EX-101.DEF 180104
32 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsha-20220331_lab.xml EX-101.LAB 400447
33 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsha-20220331_pre.xml EX-101.PRE 309510
80 EXTRACTED XBRL INSTANCE DOCUMENT tsha-10q_20220331_htm.xml XML 1025978
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39536 | Film No.: 22925736
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences